Nicholas Fidelman, MD (he/him/his)

Professor
University Of California San Francisco

Presentation(s):

• Post-procedure Hyponatremia in Patients Undergoing Liver Embolotherapy for Neuroendocrine Tumor Metastases

  Monday, March 6, 2023
  3:45 PM – 3:54 PM

  Disclosure(s): Boston Scientific: Research Grant or Support (); Merck: Research Grant or Support (); Sirtex Medical: Research Grant or Support ()

• Harnessing Immune System Activation through Imaging-Guided Procedures

  Tuesday, March 7, 2023
  9:09 AM – 9:22 AM

  Disclosure(s): Boston Scientific: Research Grant or Support (); Merck: Research Grant or Support (); Sirtex Medical: Research Grant or Support ()

• Interventional Oncology Complication

  Wednesday, March 8, 2023
  1:52 PM – 2:05 PM

  Disclosure information not submitted.

• Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for Downstaging of Hepatocellular Carcinoma Before Liver Transplant

  Wednesday, March 8, 2023
  3:00 PM – 3:09 PM

  Disclosure(s): Boston Scientific: Research Grant or Support (); Merck: Research Grant or Support (); Sirtex Medical: Research Grant or Support ()

• Socioeconomic and Survival Analysis of Radioembolization in Patients with Intrahepatic Cholangiocarcinoma: A Propensity Score Adjusted Analysis

  Wednesday, March 8, 2023
  3:27 PM – 3:36 PM

  Disclosure(s): Boston Scientific: Research Grant or Support (); Merck: Research Grant or Support (); Sirtex Medical: Research Grant or Support ()

• Phase I Prospective Trial of TAS-102 (trifluridine and tipiracil) and Radioembolization with 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases

  Wednesday, March 8, 2023
  3:45 PM – 3:54 PM

  Disclosure(s): Boston Scientific: Research Grant or Support (); Merck: Research Grant or Support (); Sirtex Medical: Research Grant or Support ()